Financials

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash $ 230 $ 923
Accounts receivable, net 1 4
Inventories, net 1,782 1,779
Prepaid expenses and other current assets 161 163
Total current assets 2,174 2,869
Deferred offering costs 96 102
Fixed assets, net 173 184
Intangible assets, net 1,568 1,640
Total assets 4,011 4,795
Current liabilities:    
Accounts payable 184 176
Accrued expenses and other current liabilities 263 255
Total current liabilities 447 431
Total liabilities 447 431
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $.001 par value; 500,000 shares authorized; no shares issued and outstanding
Common stock, $.001 par value; 12,000,000 shares authorized at March 31, 2018 and at December 31, 2017; 6,536,046 and 6,340,604 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 7 6
Additional paid-in capital 36,614 36,202
Accumulated deficit (33,057) (31,844)
Total stockholders' equity 3,564 4,364
Total liabilities and stockholders' equity $ 4,011 $ 4,795
v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Statements of Operations [Abstract]    
Net revenues $ 57 $ 150
Cost of sales 31 135
Gross profit 26 15
Selling, marketing and research 394 300
Personnel and benefits 417 333
General and administrative 427 504
Total operating expenses 1,238 1,137
Operating loss (1,212) (1,122)
Other (expense) income, net (1) 5
Net loss $ (1,213) $ (1,117)
Net loss per share attributable to common shareholders:    
Basic and diluted $ (0.19) $ (0.20)
Weighted average number of common shares outstanding:    
Basic and diluted 6,504,590 5,627,705
v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows From Operating Activities:    
Net loss $ (1,213) $ (1,117)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 11 13
Amortization 72 53
Stock-based compensation 123 41
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 3 (57)
Increase in inventories (3) (3)
Decrease (increase) in prepaid expenses 2 (181)
Decrease in deferred revenue (56)
Increase (decrease) in accounts payable and accrued expenses 16 (121)
Net cash used in operating activities (989) (1,428)
Cash Flows From Financing Activities:    
Deferred offering costs from at the market transaction (125)
Proceeds from registered direct offering of common stock 296 1,926
Net cash provided by financing activities 296 1,801
Net (decrease) increase in cash (693) 373
Cash at beginning of period 923 1,866
Cash at end of period 230 2,239
Supplemental schedule of non-cash investing and financing activities:    
Recognition of deferred offering costs $ 6